Maxifed is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Mcr American Pharmaceuticals, Inc.. The primary component is Guaifenesin; Pseudoephedrine Hydrochloride.
Product ID | 58605-101_f954e296-1429-4985-9d04-a20b67e2cf71 |
NDC | 58605-101 |
Product Type | Human Otc Drug |
Proprietary Name | Maxifed |
Generic Name | Guaifenesin And Pseudoephedrine Hydrochloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2018-04-01 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | MCR American Pharmaceuticals, Inc. |
Substance Name | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
Active Ingredient Strength | 360 mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2018-04-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2018-04-01 |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-04-01 |
Ingredient | Strength |
---|---|
GUAIFENESIN | 360 mg/1 |
SPL SET ID: | 8a1be614-2a78-4899-9697-774479f2daa5 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
58605-101 | Maxifed | GUAIFENESIN and Pseudoephedrine Hydrochloride |
66992-281 | Entex T | Guaifenesin and Pseudoephedrine Hydrochloride |
79903-125 | equate mucus d | guaifenesin and pseudoephedrine hydrochloride |
0363-0077 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
41415-994 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
51660-071 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
62011-0475 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
0363-9930 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
0536-1333 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
51316-993 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
70000-0580 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
51316-970 | MAXIMUM STRENGTH Mucus D | guaifenesin and pseudoephedrine hydrochloride |
50090-1075 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
50090-1076 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
63824-041 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
63824-057 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
68258-3035 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
70518-0523 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
0536-1137 | Mucus Relief D | Guaifenesin and Pseudoephedrine Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MAXIFED 75130397 2242345 Live/Registered |
MCR American Pharmaceuticals, Inc. 1996-07-05 |
MAXIFED 74546782 not registered Dead/Abandoned |
JOHNSON & JOHNSON 1994-07-07 |
MAXIFED 74026406 not registered Dead/Abandoned |
Johnson & Johnson 1990-02-06 |